Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-02 11:02 am Purchase | 2025-03-31 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 10,042,092 10.100% | 4,602,759 (+84.62%) | Filing History |
| 2025-02-14 4:55 pm Sale | 2024-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX L.P. | 4,600,747 5.600% | -902,907 (-16.41%) | Filing History |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 5,439,333 6.600% | -961,813 (-15.03%) | Filing History |
| 2025-02-05 7:30 pm Purchase | 2024-12-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners L.P. | 8,239,123 9.900% | 31,000 (+0.38%) | Filing History |
| 2025-01-10 9:46 pm Sale | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 6,531,099 7.920% | -2,862,790 (-30.48%) | Filing History |
| 2024-11-12 09:50 am Sale | 2024-11-08 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 6,401,146 7.766% | -2,552,654 (-28.51%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 7,748,277 9.400% | 0 (Unchanged) | Filing History |
| 2024-11-07 09:56 am Purchase | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners L.P. | 8,208,123 9.900% | 4,102,370 (+99.92%) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 7,748,277 9.400% | 1,086,234 (+16.30%) | Filing History |
| 2024-10-17 11:50 am Sale | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | STATE STREET CORP STT | 3,929,557 4.800% | -686,801 (-14.88%) | Filing History |
| 2024-02-14 3:18 pm Sale | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX L.P. | 5,503,654 6.800% | -367,496 (-6.26%) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | Beam Therapeutics Inc. BEAM | The Vanguard Group | 7,164,843 8.790% | 891,213 (+14.21%) | Filing History |
| 2024-02-12 3:38 pm Sale | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners L.P. | 4,105,753 5.000% | -7,716 (-0.19%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 8,953,800 10.985% | 1,184,784 (+15.25%) | Filing History |
| 2024-02-06 07:27 am Sale | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,076,117 3.800% | -568,456 (-15.60%) | Filing History |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 9,393,889 11.530% | 1,180,758 (+14.38%) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 6,662,043 8.200% | 1,423,763 (+27.18%) | Filing History |
| 2024-01-24 08:42 am Purchase | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | STATE STREET CORP STT | 4,616,358 5.660% | 4,616,358 (New Position) | Filing History |
| 2023-09-22 3:20 pm Purchase | 2023-09-13 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners L.P. | 4,113,469 5.200% | 713,548 (+20.99%) | Filing History |
| 2023-03-17 06:04 am Purchase | 2023-03-09 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,644,573 5.000% | 766,276 (+26.62%) | Filing History |